CCR6 and COVID-19: Last, to further support the presence of TRM17 cells in the lungs of patients with COVID-19, we first performed immunofluorescence staining showing the presence of CD4+ cells expressing CCR6 in the perivascular infiltrate of the lungs (Fig. 5D and fig.